Lovenox


Also found in: Medical, Wikipedia.

Lo·ve·nox

 (lō′və-nŏks′)
A trademark for the sodium form of the drug enoxaparin.
References in periodicals archive ?
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as "bridge" therapy.
now part of Sanofi) took that approach about 10 years ago when it was trying to ward off competition for Lovenox, its blood thinner.
Satrom was immediately given an injection of Lovenox, an anticoagulant that she must continue to inject twice a day until the baby is born, sometime in March.
4 million, primarily due to declining sales of Eloxatin (-80%), Lovenox (-13%) and Aprovel (-34%).
She was evaluated by our pulmonologist and hematologist, was started on shots of Lovenox (anti-coagulant or "blood thinner") and discharged home to close follow-up by these specialists.
What upset the Senate investigative panel, however, was that none of these ostensibly unbiased third parties had disclosed to the FDA that they had been paid by Sanofi to support the lucrative Lovenox monopoly.
31 October 2011 - US generic drugs maker Watson Pharmaceuticals Inc (NYSE:WPI) confirmed on Friday that the US District Court for the District of Massachusetts had granted Momenta Pharmaceuticals Inc (NASDAQ:MNTA) and Sandoz Inc a preliminary injunction preventing Watson and Amphastar Pharmaceuticals Inc from marketing or selling its Enoxaparin Sodium Injection, a generic equivalent to Sanofi-aventis' (EPA:SAN) LOVENOX.
Amphastar Pharmaceuticals Inc's Enoxaparin Sodium Injection is the generic equivalent to Sanofi-aventis' LOVENOX, which is indicated in the prophylaxis and treatment of deep vein thrombosis and prophylaxis of ischemic complications in unstable angina and non-Q-wave myocardial infarction.
Novartis' newest products generated 20% of quarterly sales, and the company saw strong demand for its new generic version of Sanofi-Aventis SA's (Paris FRA) blood thinner Lovenox as well as for cancer drug and blockbuster hopeful Afinitor.
On Friday, Sanofi-Aventis said profit may fall this year after US regulators approved a generic rival to its Lovenox blood thinner that had been generating sales of over pounds 3bn a year.
regulators approved a generic form of the Lovenox blood thinner, its No.